<sup>177</sup> Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II StudyAmar U. Kishan, Jérémie Calais, R. Nabong et al.|Journal of Clinical Oncology|2025Cited by 24
Genomic and Transcriptomic Profiling of Radiation-Resistant, Locally Recurrent Prostate CancerBeth K. Neilsen, Amar U. Kishan, Rong Rong Huang et al.|International Journal of Radiation Oncology*Biology*Physics|2025Cited by 0